Insud Pharma opens development & manufacturing centre for novel SMA oligonucleotide in Hyderabad

Spanish pharmaceutical company Insud Pharma has established a specialized oligonucleotides center at its Chemo India Formulation Private Limited campus in Hyderabad. This center is dedicated to research and production of oligonucleotides, with the capacity to produce Nusinersen, an antisense oligonucleotide for treating Spinal Muscular Atrophy. It has received approvals from US FDA, Spanish Health Agency.

from Science News - Times of India https://ift.tt/9wCYZoS
via